Detalhe da pesquisa
1.
Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype.
Ann Oncol
; 31(9): 1178-1185, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32387417
2.
Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1).
J Intern Med
; 272(1): 85-92, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22211699
3.
Prostate involvement during sexually transmitted infections as measured by prostate-specific antigen concentration.
Br J Cancer
; 105(5): 602-5, 2011 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21792196
4.
Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy.
Nat Commun
; 11(1): 5070, 2020 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33033260
5.
Biosynthesis of titin in cultured skeletal muscle cells.
J Cell Biol
; 109(5): 2189-95, 1989 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-2681227
6.
Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search.
Science
; 274(5291): 1371-4, 1996 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-8910276
7.
TET2 binds the androgen receptor and loss is associated with prostate cancer.
Oncogene
; 36(15): 2172-2183, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27819678
8.
Models for development of nonreceptor methods for distinguishing androgen-sensitive and -insensitive prostatic tumors.
Cancer Res
; 39(7 Pt 1): 2652-9, 1979 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-445468
9.
ras gene mutations in human prostate cancer.
Cancer Res
; 50(21): 6830-2, 1990 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2208148
10.
Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.
Cancer Res
; 51(17): 4716-20, 1991 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-1873816
11.
Identification of 12p as a region of frequent deletion in advanced prostate cancer.
Cancer Res
; 58(24): 5652-5, 1998 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-9865716
12.
Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.
Cancer Res
; 53(15): 3585-90, 1993 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-8339265
13.
A novel human cell culture model for the study of familial prostate cancer.
Cancer Res
; 61(16): 5969-73, 2001 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11507036
14.
Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11.
Cancer Res
; 52(12): 3486-90, 1992 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-1596907
15.
Cadherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinoma.
Cancer Res
; 57(13): 2741-8, 1997 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9205085
16.
Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
Cancer Res
; 55(21): 4813-7, 1995 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7585512
17.
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.
Cancer Res
; 54(14): 3929-33, 1994 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-7518346
18.
Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.
Cancer Res
; 58(23): 5280-4, 1998 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9850048
19.
Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
Cancer Res
; 58(23): 5310-4, 1998 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-9850055
20.
Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
Cancer Res
; 59(10): 2329-31, 1999 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-10344738